
Protagen AG joins MATURA Consortium to support Identification of Treatment Response Predictors in Rheumatoid Arthritis
Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has today announced that it will join the MATURA Consortium
Read more